Even though SASH1 was globally down-regulated among all tumors and its expression associated with favorable prognosis, certain subgroups like estrogen receptor positive cancers showed a significantly reduced survival for cases with high SASH1 expression [36]. This evidence concerns the gene ESR1 and cancer.